Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting Program.

Saved in:
Bibliographic Details
Title: Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting Program.
Authors: Galluppi GR; Sumitomo Pharma America, Marlborough, Massachusetts, USA., Ahamadi M; Sanofi US, Bridgewater, New Jersey, USA., Bhattacharya S; Astellas Pharma US Inc., Cambridge, Massachusetts, USA., Budha N; BeiGene USA Inc., San Mateo, California, USA., Gheyas F; Merck & Co., Inc, Rahway, New Jersey, USA., Li CC; Genentech Inc, South San Francisco, California, USA., Chen Y; Genentech Inc, South San Francisco, California, USA., Dosne AG; The Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium., Kristensen NR; Novo Nordisk A/S, Bagsvaerd, Denmark., Magee M; GSK, Phoenixville, Pennsylvania, USA., Samtani MN; Johnson & Johnson Innovative Medicine, Raritan, New Jersey, USA., Sinha V; Novartis Institute of Biomedical Research, Berwyn, Pennsylvania, USA., Taskar K; GSK, Stevenage, UK., Upreti VV; Amgen Inc., South San Fracisco, California, USA., Yang J; Astellas Pharma Inc., Northbrook, Illinois, USA., Cook J; A2-Ai LLC, Ann Arbor, Michigan, USA.
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Aug; Vol. 116 (2), pp. 282-288. Date of Electronic Publication: 2024 Mar 22.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38519861
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting Program.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Galluppi+GR%22">Galluppi GR</searchLink>; Sumitomo Pharma America, Marlborough, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Ahamadi+M%22">Ahamadi M</searchLink>; Sanofi US, Bridgewater, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Bhattacharya+S%22">Bhattacharya S</searchLink>; Astellas Pharma US Inc., Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Budha+N%22">Budha N</searchLink>; BeiGene USA Inc., San Mateo, California, USA.<br /><searchLink fieldCode="AU" term="%22Gheyas+F%22">Gheyas F</searchLink>; Merck & Co., Inc, Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Li+CC%22">Li CC</searchLink>; Genentech Inc, South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Genentech Inc, South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Dosne+AG%22">Dosne AG</searchLink>; The Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Kristensen+NR%22">Kristensen NR</searchLink>; Novo Nordisk A/S, Bagsvaerd, Denmark.<br /><searchLink fieldCode="AU" term="%22Magee+M%22">Magee M</searchLink>; GSK, Phoenixville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Samtani+MN%22">Samtani MN</searchLink>; Johnson & Johnson Innovative Medicine, Raritan, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Sinha+V%22">Sinha V</searchLink>; Novartis Institute of Biomedical Research, Berwyn, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Taskar+K%22">Taskar K</searchLink>; GSK, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Upreti+VV%22">Upreti VV</searchLink>; Amgen Inc., South San Fracisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Yang+J%22">Yang J</searchLink>; Astellas Pharma Inc., Northbrook, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Cook+J%22">Cook J</searchLink>; A2-Ai LLC, Ann Arbor, Michigan, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2024 Aug; Vol. 116 (2), pp. 282-288. <i>Date of Electronic Publication: </i>2024 Mar 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38519861
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cpt.3245
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 282
    Titles:
      – TitleFull: Considerations for Industry-Preparing for the FDA Model-Informed Drug Development (MIDD) Paired Meeting Program.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Galluppi GR
      – PersonEntity:
          Name:
            NameFull: Ahamadi M
      – PersonEntity:
          Name:
            NameFull: Bhattacharya S
      – PersonEntity:
          Name:
            NameFull: Budha N
      – PersonEntity:
          Name:
            NameFull: Gheyas F
      – PersonEntity:
          Name:
            NameFull: Li CC
      – PersonEntity:
          Name:
            NameFull: Chen Y
      – PersonEntity:
          Name:
            NameFull: Dosne AG
      – PersonEntity:
          Name:
            NameFull: Kristensen NR
      – PersonEntity:
          Name:
            NameFull: Magee M
      – PersonEntity:
          Name:
            NameFull: Samtani MN
      – PersonEntity:
          Name:
            NameFull: Sinha V
      – PersonEntity:
          Name:
            NameFull: Taskar K
      – PersonEntity:
          Name:
            NameFull: Upreti VV
      – PersonEntity:
          Name:
            NameFull: Yang J
      – PersonEntity:
          Name:
            NameFull: Cook J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2024 Aug
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1532-6535
          Numbering:
            – Type: volume
              Value: 116
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Clinical pharmacology and therapeutics
              Type: main
ResultId 1